Severe tricuspid regurgitation is no longer a bystander disease.
In this elderly patient with persistent symptoms despite optimised medical therapy, a comprehensive multimodality assessment becomes key to determining the right timing and the most appropriate transcatheter strategy.
12 May 2026
From assessment to strategy: choosing the optimal treatment for severe tricuspid regurgitation
This case has been accredited by EBAC with 1 CME credit
Severe tricuspid regurgitation is no longer a bystander disease.
In this elderly patient with persistent symptoms despite optimised medical therapy, a comprehensive multimodality assessment becomes key to determining the right timing and the most appropriate transcatheter strategy.
Authors
Interventional cardiologist / Cardiologist
University of Brescia - Brescia, Italy
Interventional cardiologist / Cardiologist
University of Brescia - Brescia, Italy
Log in or create account for free
Content available!
Please log in to view this content.
Your free My PCR account will enable you to:
26 Nov 2025